Molecular docking studies are of great importance to discover potential drugs against COVID-19, which involves the cardiovascular system [42,43,44] as infection is initiated by the entry of the S-protein via ACE2, a peptide of the renin-angiotensin system (RAS). The gene discussed is PROS1; the disease is infection.